A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens.
Allergens
/ immunology
Animals
Antigens, Dermatophagoides
/ immunology
Arthropod Proteins
/ immunology
Case-Control Studies
Cysteine Endopeptidases
/ immunology
Cytokines
/ metabolism
Enzyme-Linked Immunosorbent Assay
Epitopes, T-Lymphocyte
/ immunology
Humans
Hypersensitivity
/ immunology
Immunoglobulin E
/ immunology
Immunoglobulin G
/ immunology
Peptides
/ immunology
Pyroglyphidae
/ immunology
T cell epitope
allergen
house dust mite allergy
recombinant allergen
synthetic peptide
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
09
11
2018
revised:
29
04
2019
accepted:
01
05
2019
pubmed:
23
6
2019
medline:
10
9
2020
entrez:
23
6
2019
Statut:
ppublish
Résumé
In the house dust mite (HDM) Dermatophagoides pteronyssinus, Der p 1, 2, 5, 7, 21, and 23 have been identified as the most important allergens. The aim of this study was to define hypoallergenic peptides derived from the sequences of the six allergens and to use the peptides and the complete allergens to study antibody, T cell, and cytokine responses in sensitized and nonsensitized subjects. IgE reactivity of HDM-allergic and non-HDM-sensitized individuals to 15 HDM allergens was established using ImmunoCAP ISAC technology. Thirty-three peptides covering the sequences of the six HDM allergens were synthesized. Allergens and peptides were tested for IgE and IgG reactivity by ELISA and ImmunoCAP, respectively. Allergenic activity was determined by basophil activation. CD4+ T cell and cytokine responses were determined in PBMC cultures by CFSE dilution and Luminex technology, respectively. House dust mite allergics showed IgE reactivity only to complete allergens, whereas 31 of the 33 peptides lacked relevant IgE reactivity and allergenic activity. IgG antibodies of HDM-allergic and nonsensitized subjects were directed against peptide epitopes and higher allergen-specific IgG levels were found in HDM allergics. PBMC from HDM-allergics produced higher levels of IL-5 whereas non-HDM-sensitized individuals mounted higher levels of IFN-gamma, IL-17, pro-inflammatory cytokines, and IL-10. IgG antibodies in HDM-allergic patients recognize peptide epitopes which are different from the epitopes recognized by IgE. This may explain why naturally occurring allergen-specific IgG antibodies do not protect against IgE-mediated allergic inflammation. A mix of hypoallergenic peptides containing T cell epitopes of the most important HDM allergens was identified.
Sections du résumé
BACKGROUND
In the house dust mite (HDM) Dermatophagoides pteronyssinus, Der p 1, 2, 5, 7, 21, and 23 have been identified as the most important allergens. The aim of this study was to define hypoallergenic peptides derived from the sequences of the six allergens and to use the peptides and the complete allergens to study antibody, T cell, and cytokine responses in sensitized and nonsensitized subjects.
METHODS
IgE reactivity of HDM-allergic and non-HDM-sensitized individuals to 15 HDM allergens was established using ImmunoCAP ISAC technology. Thirty-three peptides covering the sequences of the six HDM allergens were synthesized. Allergens and peptides were tested for IgE and IgG reactivity by ELISA and ImmunoCAP, respectively. Allergenic activity was determined by basophil activation. CD4+ T cell and cytokine responses were determined in PBMC cultures by CFSE dilution and Luminex technology, respectively.
RESULTS
House dust mite allergics showed IgE reactivity only to complete allergens, whereas 31 of the 33 peptides lacked relevant IgE reactivity and allergenic activity. IgG antibodies of HDM-allergic and nonsensitized subjects were directed against peptide epitopes and higher allergen-specific IgG levels were found in HDM allergics. PBMC from HDM-allergics produced higher levels of IL-5 whereas non-HDM-sensitized individuals mounted higher levels of IFN-gamma, IL-17, pro-inflammatory cytokines, and IL-10.
CONCLUSION
IgG antibodies in HDM-allergic patients recognize peptide epitopes which are different from the epitopes recognized by IgE. This may explain why naturally occurring allergen-specific IgG antibodies do not protect against IgE-mediated allergic inflammation. A mix of hypoallergenic peptides containing T cell epitopes of the most important HDM allergens was identified.
Identifiants
pubmed: 31228873
doi: 10.1111/all.13956
pmc: PMC7078969
doi:
Substances chimiques
Allergens
0
Antigens, Dermatophagoides
0
Arthropod Proteins
0
Cytokines
0
Epitopes, T-Lymphocyte
0
Immunoglobulin G
0
Peptides
0
Immunoglobulin E
37341-29-0
Cysteine Endopeptidases
EC 3.4.22.-
Dermatophagoides pteronyssinus antigen p 1
EC 3.4.22.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2461-2478Subventions
Organisme : Austrian Science Fund FWF
ID : F 4605
Pays : Austria
Organisme : Austrian Science Fund (FWF)
ID : F4602
Pays : International
Organisme : Megagrant of the Government of the Russian Federation
ID : 14.W03.31.0024
Pays : International
Organisme : Austrian Science Fund (FWF)
ID : DK W 1248-B30
Pays : International
Organisme : Austrian Science Fund (FWF)
ID : F4605
Pays : International
Organisme : Medizinische Universität Wien
Pays : International
Organisme : Austrian Science Fund FWF
ID : P 29991
Pays : Austria
Informations de copyright
© 2019 The Authors. Allergy Published by John Wiley & Sons Ltd.
Références
Clin Exp Allergy. 2002 Oct;32(10):1461-7
pubmed: 12372126
J Allergy Clin Immunol. 2016 Feb;137(2):351-7
pubmed: 26853127
J Allergy Clin Immunol. 2017 Feb;139(2):541-549.e8
pubmed: 27793411
J Allergy Clin Immunol. 2013 Jan;131(1):103-9.e1-7
pubmed: 22981787
EBioMedicine. 2018 May;31:66-78
pubmed: 29678672
Sci Rep. 2017 Sep 14;7(1):11657
pubmed: 28912492
J Allergy Clin Immunol. 1994 Mar;93(3):628-34
pubmed: 7512103
J Allergy Clin Immunol. 2018 Aug;142(2):398-400
pubmed: 29906529
Allergy. 2019 Dec;74(12):2461-2478
pubmed: 31228873
Nat Rev Immunol. 2012 Oct;12(10):721-8
pubmed: 22955843
Lancet. 2005 Jan 8-14;365(9454):142-9
pubmed: 15639296
J Allergy Clin Immunol. 2016 Oct;138(4):984-1010
pubmed: 27577879
Curr Allergy Asthma Rep. 2018 Jun 9;18(7):39
pubmed: 29886521
Clin Exp Allergy. 2015 Oct;45(10):1601-12
pubmed: 25652035
Drug Discov Today. 2015 Jan;20(1):122-8
pubmed: 25450771
J Allergy Clin Immunol. 2017 Dec;140(6):1485-1498
pubmed: 29221580
J Allergy Clin Immunol. 1994 May;93(5):891-9
pubmed: 7514196
J Allergy Clin Immunol. 2006 Aug;118(2):361-7
pubmed: 16890759
Curr Top Microbiol Immunol. 2011;352:107-19
pubmed: 21567311
J Allergy Clin Immunol. 2018 Oct;142(4):1322-1330
pubmed: 29428391
Allergy. 2015 Oct;70(10):1222-9
pubmed: 26043182
J Allergy Clin Immunol. 2015 Oct;136(4):1083-91
pubmed: 25956509
J Immunol. 1993 Apr 15;150(8 Pt 1):3643-50
pubmed: 8468493
Adv Immunol. 2018;138:195-256
pubmed: 29731005
Curr Allergy Asthma Rep. 2016 Feb;16(2):14
pubmed: 26768622
Semin Immunol. 2017 Apr;30:67-80
pubmed: 28939389
Immunol Lett. 2017 Sep;189:19-26
pubmed: 28472641
Eur J Clin Invest. 2008 Dec;38(12):959-65
pubmed: 19021722
Eur Respir J. 1995 Mar;8(3):483-91
pubmed: 7789502
J Allergy Clin Immunol. 2018 Aug;142(2):497-509.e9
pubmed: 29361332
J Korean Med Sci. 2013 Jan;28(1):74-9
pubmed: 23341715
J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1845-1855.e2
pubmed: 30297269
Int Arch Allergy Appl Immunol. 1990;91(2):124-9
pubmed: 2187817
Chem Immunol Allergy. 2014;100:234-42
pubmed: 24925403
J Allergy Clin Immunol. 2017 Feb;139(2):388-399
pubmed: 28183433
J Immunol. 1992 Feb 1;148(3):738-45
pubmed: 1370514
Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250
pubmed: 27288833
Mol Immunol. 2018 Aug;100:120-125
pubmed: 29602574
Clin Exp Allergy. 2000 Jul;30(7):934-43
pubmed: 10848915
Adv Exp Med Biol. 1994;347:11-6
pubmed: 7526633
EBioMedicine. 2016 Sep;11:43-57
pubmed: 27650868
Allergy. 1998;53(48 Suppl):108-14
pubmed: 10096821
J Allergy Clin Immunol. 2002 Jul;110(1):102-9
pubmed: 12110828
J Allergy Clin Immunol. 2005 Feb;115(2):399-404
pubmed: 15696102
J Immunol. 1993 Aug 15;151(4):2326-35
pubmed: 7688399
Methods. 2014 Mar 1;66(1):106-19
pubmed: 24161540
Clin Transl Allergy. 2018 Jun 4;8:19
pubmed: 29881542
Immunol Today. 1994 Feb;15(2):91
pubmed: 7512343
Expert Rev Clin Immunol. 2017 Apr;13(4):297-299
pubmed: 28162009
World Allergy Organ J. 2017 Apr 18;10(1):14
pubmed: 28451053
J Allergy Clin Immunol. 2018 Nov;142(5):1656-1659.e9
pubmed: 30059698
J Allergy Clin Immunol. 2011 Jan;127(1):89-97, 97.e1-14
pubmed: 21211644